Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19

posted in: Pediatric News | 0
ORIGINAL ARTICLE FROM NEJM
Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19
Alexandre B. Cavalcanti and Others
Patients with confirmed or suspected Covid-19 were randomized to hydroxychloroquine with azithromycin, hydroxychloroquine alone, or usual care. The primary outcome was clinical status at 15 days using a seven-level ordinal scale. There was no significant difference between groups in the primary outcome.